• +660 9238 93971
  • yanliangjie@gmail.com
Normal weight, but could IVF success still be affected? A study of 1033 women reveals an easily overlooked metabolic issue.

Normal weight, but could IVF success still be affected? A study of 1033 women reveals an easily overlooked metabolic issue.

Published: 2026-09-30 |Views: 8223

Normal Weight, Yet IVF Success May Be Affected? A Study of 1,033 Women Reveals an Overlooked Metabolic Issue

You are not overweight, and you usually pay attention to diet and exercise. So why has conception been delayed? Why is it that even after IVF, follicle development and endometrial thickness appear favorable, yet the final pregnancy outcome is not as hoped?

Many people believe that insulin resistance is mainly a concern for women with obesity. In reality, normal weight does not necessarily mean metabolic health. Some women may be slim but still have abdominal fat accumulation, abnormal blood lipids, or reduced insulin sensitivity.

These subtle metabolic changes may be associated with ovarian function, endocrine regulation, and assisted reproductive outcomes.

A 2025 study published in the international reproductive medicine journal Human Reproduction analyzed 1,033 women without polycystic ovary syndrome who were undergoing assisted reproductive treatment. It found that insulin resistance was significantly associated with a higher risk of miscarriage and a lower live birth rate.

This study reminds us that factors affecting fertility include not only eggs, sperm, and the uterine environment; the body's metabolic status also deserves attention.

Today, Huanqiu Xinsheng looks at why insulin resistance may affect IVF treatment from the perspectives of reproductive medicine and metabolic health, and how families planning third-generation IVF in Thailand can approach preconception health management.

1. Why Can Insulin Resistance Occur Even Without Excess Weight?

Insulin is an important hormone that regulates blood glucose and energy metabolism. After eating, blood glucose rises. Insulin helps tissues such as muscle and fat use or store energy while inhibiting excessive glucose release from the liver.

When body tissues respond less effectively to insulin, the body may need to secrete more insulin to maintain normal blood glucose levels. This state is called insulin resistance.

It is worth noting that insulin resistance is not an issue exclusive to people with obesity.

The body's muscles, liver, and adipose tissue all participate in energy metabolism, and insulin resistance may occur to different degrees in different tissues.

Among these, adipose tissue insulin resistance is a direction worth attention.

Under normal circumstances, insulin not only regulates blood glucose but also inhibits fat cells from excessively breaking down stored fat. When adipose tissue responds less to insulin, this inhibitory effect may weaken, allowing more free fatty acids to enter the bloodstream.

Excess free fatty acids may further interfere with insulin signaling in muscle and the liver, and may interact with oxidative stress, chronic low-grade inflammation, and abnormal lipid metabolism.

At the same time, if the ability of skeletal muscle to use glucose declines, the metabolic fate of postprandial glucose may also change.

In 2007, Petersen and colleagues found that in young, lean individuals with insulin resistance, muscle glycogen synthesis capacity was markedly reduced, while hepatic lipid synthesis was significantly increased.

This finding suggests that metabolic abnormalities are not necessarily accompanied by obvious weight gain.

For women preparing for pregnancy, body mass index (BMI) is only one reference indicator of physical status. Even if BMI is within the normal range, further evaluation may be needed if there is increased waist circumference, abnormal blood lipids, glucose metabolism problems, or a relevant family history.

However, increased abdominal fat or relatively high blood lipids alone cannot be used to directly diagnose adipose tissue insulin resistance. The specific situation still needs to be assessed comprehensively in light of medical history, physical examination, and necessary laboratory indicators.

2. Why Might Insulin Resistance Affect Female Fertility?

The female reproductive system has complex links with the body's energy metabolism.

From follicle recruitment and development to oocyte maturation, continuous energy supply is required. Granulosa cells surrounding the oocyte participate in glucose metabolism and provide important nutritional and metabolic support to the oocyte.

At the same time, the female ovulatory cycle is regulated by hormones among the hypothalamus, pituitary, and ovaries. Estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone all participate in follicular development and endometrial changes.

When significant insulin resistance persists over time, it may affect some reproductive endocrine processes through hyperinsulinemia, lipid metabolism disorders, and inflammation-related signaling.

Especially in patients with polycystic ovary syndrome (PCOS), the link between insulin resistance, hyperandrogenic states, and ovulatory dysfunction has received widespread attention.

However, it should be emphasized that women without PCOS may also have insulin resistance.

From a reproductive medicine perspective, researchers are exploring whether metabolic abnormalities may affect the follicular microenvironment, oocyte development, and endometrial function through oxidative stress, cellular energy metabolism, and inflammatory responses.

However, these mechanisms do not mean that all patients with insulin resistance will experience reduced egg quality or embryo implantation failure.

Similarly, early follicular development, abnormal estradiol fluctuations, or menstrual cycle irregularities cannot simply be attributed to insulin resistance. Ovarian reserve, age, and other reproductive endocrine factors all need independent evaluation.

What truly deserves attention is that reproductive health does not operate as an isolated system; metabolic status may be one of the factors affecting assisted reproductive outcomes.

3. A Study of 1,033 IVF Women: What Is the Relationship Between Insulin Resistance and Live Birth Rate?

In 2025, Human Reproduction published a multicenter retrospective cohort study in which researchers analyzed 1,033 women undergoing in vitro fertilization (IVF).

None of these women had PCOS, and their BMI did not exceed 30 kg/m².

The study found that about 30.5% of participants had insulin resistance.

Regarding pregnancy outcomes, the two groups showed differences worth noting:

  • Clinical miscarriage proportion: 26.3% in the insulin resistance group and 17.6% in the insulin-sensitive group.
  • Live birth rate: 9.6% in the insulin resistance group and 24.5% in the insulin-sensitive group.
  • After adjustment for relevant factors, the insulin resistance group still had a higher risk of miscarriage, and live birth outcomes were also relatively poorer.

The study reported adjusted relative risk measures of aRR=1.439 and aRR=0.422, respectively.

This means that, in this study population, insulin resistance was statistically associated with adverse assisted reproductive outcomes.

However, several issues should not be overlooked when interpreting these data.

First, this was a retrospective observational study. It can identify associations between variables, but it cannot by itself prove that insulin resistance directly causes IVF failure.

Second, 9.6% and 24.5% are live birth rates observed under specific study conditions. They are not the actual success rates of all women with insulin resistance, and they certainly cannot be used directly to predict an individual patient's treatment outcome.

Finally, the study focused on the relationship between insulin resistance and IVF outcomes. These results cannot be directly equated with the independent effect of adipose tissue-specific insulin resistance.

Therefore, a scientific interpretation should be: insulin resistance may be a metabolic risk factor worth evaluating in assisted reproductive treatment, but its degree of impact and whether improving insulin sensitivity can reliably increase live birth rates still require confirmation by more high-quality research.

For families preparing for IVF treatment, the value of this study is that it reminds us not to focus only on follicle count, endometrial thickness, and embryo grade, but also to pay attention to overall metabolic health in light of individual circumstances.

4. How Can Women Preparing for Pregnancy Improve Insulin Sensitivity?

If insulin resistance or other metabolic abnormalities are present, the focus of preconception management is not blind weight loss but improving the body's ability to use and store energy.

1. Adjust Diet Quality, Rather Than Simply Eating Less

For women with normal weight but metabolic problems, excessive dieting may lead to insufficient nutrient intake, which may instead be detrimental to a normal menstrual cycle and reproductive health.

A more reasonable approach is to reduce the intake of sugary drinks, excessive refined carbohydrates, and foods high in saturated fat, while appropriately increasing whole grains, vegetables, legumes, fish, and high-quality protein.

Foods rich in unsaturated fatty acids, such as deep-sea fish, nuts, and olive oil, can also be part of a balanced diet.

Such dietary adjustments may help improve overall metabolic health, but it should not be assumed that simply increasing one nutrient can directly improve egg quality or IVF success rates.

2. Focus on Muscle Strength: Exercise Is Not Just for Weight Loss

Skeletal muscle is an important tissue for glucose use in the body and a key factor affecting insulin sensitivity.

Regular exercise can promote muscle glucose use, improve cardiorespiratory fitness, and help control abdominal fat and some metabolic risk indicators.

For women preparing for pregnancy without exercise contraindications, a habit of about 150 minutes per week of moderate-intensity aerobic exercise can be gradually established, combined with appropriate resistance training twice a week.

Examples include brisk walking, cycling, swimming, and strength training with resistance bands or appropriate weights.

For women with lean limbs but relatively more abdominal fat, increasing muscle strength and improving body composition may be more meaningful than simply pursuing weight loss.

It should be noted that women who have already entered an ovarian stimulation cycle should adjust exercise intensity based on ovarian size, follicle development, and doctor's advice, avoiding vigorous jumping, twisting, and high-impact exercise to reduce risks such as ovarian torsion.

3. Pay Attention to Waist Circumference, Blood Lipids, and Glucose Metabolism, Not Just BMI

Normal weight does not completely rule out abdominal obesity, abnormal blood lipids, or glucose metabolism problems.

If a woman has obvious abdominal fat accumulation, a family history of diabetes, previous gestational diabetes, PCOS, or other metabolic risk factors, she can consult a doctor about whether further testing is needed.

Clinical evaluation may involve fasting blood glucose, glycated hemoglobin, blood lipids, and, depending on the specific situation, an oral glucose tolerance test.

Some patients may need further evaluation of insulin resistance, but not all women preparing for pregnancy need routine multi-timepoint insulin release testing.

In addition, there is currently no single routine blood test that can accurately diagnose all types of tissue-specific insulin resistance.

Therefore, tests should be selected by doctors in light of the specific situation, avoiding repeated unnecessary testing due to fear of IVF failure.

4. Consider Targeted Treatment Only When There Is a Clear Metabolic Problem

If diabetes, prediabetes, or another metabolic disease requiring treatment has been diagnosed, preconception management should be carried out under a doctor's guidance.

For some patients with insulin resistance, doctors may consider medication based on the specific diagnosis, risks, and treatment goals.

However, medications such as metformin are not suitable for all women preparing for pregnancy, nor should they be taken on one's own merely to improve IVF success rates.

Especially for women without PCOS, there is still insufficient evidence to support drugs that improve insulin resistance as routine treatment for all IVF patients.

5. Why Pay Attention to Metabolic Health Before Preparing for Third-Generation IVF in Thailand?

For families planning to travel to Thailand for assisted reproductive treatment through overseas fertility and cross-border reproductive care services, a thorough preconception evaluation can help doctors understand the patient's physical condition more comprehensively.

Third-generation IVF in Thailand typically involves ovarian stimulation, egg retrieval, fertilization, embryo culture, and, when medically indicated, preimplantation genetic testing (PGT).

PGT is mainly used to assess specific genetic risks. It cannot solve all problems affecting pregnancy, nor can it replace a woman's own endocrine and metabolic management.

Even if embryos with chromosome test results that meet expectations are obtained, pregnancy outcomes are still affected by age, the uterine environment, embryo developmental potential, and other health factors.

Therefore, for women with abnormal blood glucose, insulin resistance, or marked dyslipidemia, it is recommended to inform the reproductive doctor of the relevant medical history before entering the treatment cycle and to undergo further evaluation as needed.

At the same time, metabolic management also needs to take the actual treatment timeline into account.

For women of advanced maternal age or with diminished ovarian reserve, IVF treatment should not be indefinitely delayed in pursuit of an ideal metabolic marker. Doctors need to comprehensively assess metabolic risk, age, and ovarian reserve and reasonably arrange the timing of treatment.

During cross-border medical care, preparation of medical documents, communication about test items, scheduling of ovarian stimulation, and lifestyle management during treatment can also affect the overall care experience.

Huanqiu Xinsheng has long focused on services related to assisted reproduction in Thailand. Centered on the practical needs of families seeking fertility care overseas, it provides overseas medical accompaniment support such as hospital appointment coordination, organization of medical documents, interpretation and accompaniment during medical visits, transfer arrangements, accommodation guidance, and coordination of medical processes.

For clients with metabolic health issues, we can assist in organizing relevant test documents and provide interpretation and communication during medical visits, so that reproductive doctors can more fully understand the patient's past medical history and physical condition.

It should be emphasized that the diagnosis of insulin resistance, medication treatment, ovarian stimulation protocols, and embryo transfer arrangements should all be determined by qualified medical professionals with appropriate credentials.

The focus of Huanqiu Xinsheng's services is to help clients reduce information barriers and better cooperate with treatment through clear medical communication and orderly cross-border medical coordination.

Conclusion: IVF Success Is Not Only About Follicles and Embryos—Metabolic Health Also Deserves Attention

IVF treatment is a complex process involving multiple physiological stages.

From follicle development and oocyte maturation to fertilization, embryo culture, implantation, and pregnancy maintenance, each step is affected by multiple factors.

Recent research suggests that even women without obvious obesity may have insulin resistance, and this metabolic state is associated with some adverse assisted reproductive outcomes.

However, this does not mean that insulin resistance will necessarily cause IVF failure, nor does it mean that all women preparing for pregnancy need additional insulin testing or medication.

Truly scientific preconception management involves identifying issues that need intervention based on age, ovarian reserve, previous reproductive history, and metabolic risk, and developing a reasonable treatment plan under the guidance of a professional doctor.

For families preparing for third-generation IVF in Thailand, paying attention to eggs and embryos is important, and maintaining good overall health is also an indispensable part of the journey to parenthood.

Huanqiu Xinsheng consistently upholds the concept of full-cycle fertility management, providing clearer and more organized service support for families traveling to Thailand for fertility care through professional interpretation and medical accompaniment and cross-border medical coordination.

Let scientific evaluation be the starting point of the journey to parenthood, and let professional support accompany every step along the way.

Huanqiu Xinsheng | Full-Cycle Fertility Management

Disclaimer: This article is for assisted reproductive health education only and does not constitute individualized medical advice. The research data cited come from specific populations and cannot be used directly to predict an individual's pregnancy or live birth rate. Testing, diagnosis, and treatment of insulin resistance should be determined by a qualified physician based on the individual's actual situation.